Stay updated on Guselkumab in Psoriasis: Clinical Trial
Sign up to get notified when there's something new on the Guselkumab in Psoriasis: Clinical Trial page.

Latest updates to the Guselkumab in Psoriasis: Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe page now displays the completed ClinicalTrials.gov record for a guselkumab study in moderate-to-severe plaque psoriasis, including its study plan, eligibility criteria, locations, and outcome measures.SummaryDifference84%

- Check15 days agoChange DetectedThe site footer revision changed from v3.7.2 to v3.8.0; the page content still displays a 403 Forbidden error.SummaryDifference0.2%

- Check22 days agoChange DetectedA banner announces NIH’s transition from using “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.SummaryDifference1%

- Check29 days agoChange DetectedThe footer revision label changed from v3.7.1 to v3.7.2 while the ClinicalTrials.gov page continued to display a 403 Forbidden error.SummaryDifference0.2%

- Check36 days agoChange DetectedThe footer revision label changes from v3.7.0 to v3.7.1 while the page remains a 403 Forbidden error.SummaryDifference0.2%

- Check57 days agoChange DetectedThe study page now displays a 403 Forbidden error instead of the expected content, replacing the study details with an error screen and effectively hiding the trial information from view.SummaryDifference17%

Stay in the know with updates to Guselkumab in Psoriasis: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Guselkumab in Psoriasis: Clinical Trial page.